Atlas Trials

A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Clinical trial NCT00461786 · COMPLETED

Trial details

NCT number
NCT00461786
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPeritoneal Cancer
Start date
2004-09-01
Primary completion
2007-10-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.